Treatment options in patients with metastatic gastric cancer: current status and future perspectives
about
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancerThe role of antiangiogenic agents in the treatment of gastric cancer: A systematic review and meta-analysisSurvival benefit from S-1 as compared to Fluorouracil in Asian patients with advanced gastrointestinal cancer: a meta-analysis.Comparative effectiveness and safety between oxaliplatin-based and cisplatin-based therapy in advanced gastric cancer: A meta-analysis of randomized controlled trials.Downregulation of FKBP14 by RNA interference inhibits the proliferation, adhesion and invasion of gastric cancer cells.Bi-weekly docetaxel and 5-fluorouracil: an effective and feasible treatment for advanced gastric cancer with poor performance status.Synchronously detected secondary signet ring cell urinary bladder malignancy from the stomach masquerading as genitourinary tuberculosis.Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8.GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Association between HER2 status in gastric cancer and clinicopathological features: a retrospective study using whole-tissue sections.The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastric cancer.In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients.Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells.Gastric cancer management: Kinases as a target therapy.Inhibition of Vascular Endothelial Growth Factor Receptor 3 Reduces Migration of Gastric Cancer Cells.Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer.Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.Impressive response to immunotherapy in a metastatic gastric cancer patient: could somatic copy number alterations help patient selection?Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer.Detection of MET mRNA in gastric cancer in situ. Comparison with immunohistochemistry and sandwich immunoassays.Evaluation of short-term effectiveness of eight targeted agents combined with chemotherapy for treating esophageal-gastric junction adenocarcinoma: A network meta-analysis.Usnic Acid Induces Cycle Arrest, Apoptosis, and Autophagy in Gastric Cancer Cells In Vitro and In Vivo.Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.Phase Ib/II study of elisidepsin in metastatic or advanced gastroesophageal cancer (IMAGE trial).MicroRNA-34a regulates proliferation and apoptosis of gastric cancer cells by targeting silent information regulator 1.Nanosomal Docetaxel Lipid Suspension: A Guide to Its Use in Cancer.Could texture features from preoperative CT image be used for predicting occult peritoneal carcinomatosis in patients with advanced gastric cancer?An assessment of candidate genes to assist prognosis in gastric cancer.Immunotherapy for Gastric Cancer: Time for a Personalized Approach?LP1 from C Induces Autophagy, Apoptosis and Reduces Metastasis in Human Gastric Cancer Cell Line SGC-7901Doxorubicin-Loaded Single Wall Nanotube Thermo-Sensitive Hydrogel for Gastric Cancer Chemo-Photothermal TherapyAn anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models
P2860
Q26774538-A35DCE1B-8449-4906-B85C-1ABE2AFDB6FDQ30235387-0D1776C6-68D9-4868-B622-83BA067860BCQ33416158-41C8F17C-10B2-489B-95D0-10A5902D954EQ33432145-93A33201-6D68-40BB-AA3B-4267966EFE0FQ33597719-A8D53A07-227D-4082-A1A4-079AB123FCB5Q34447512-F3DAF4DA-ACB7-4083-BBD2-412DBF45572FQ35015780-5DCE4598-FE2C-40EA-9E89-026D33C3B7DCQ35645718-655B9747-2DB7-40E3-AA06-5E2966B17501Q35712961-9DB4DE32-8A20-42D2-B0A1-1AC66F86E4DAQ35815603-C4E02A95-81E8-47FC-A054-9BB6BA63BDA4Q35831069-BEB895A4-8278-4DC8-82B3-54188B42B9FAQ36758921-49BBB091-55B2-4059-AA72-CB3892BD84E9Q36782629-6E15F847-4DD3-44BB-9D5A-A0D1BCBCBBD5Q38602669-A630ADFE-7CDE-41F3-AFC5-D14026B9654FQ38709260-139ACBB1-F4E6-4867-8758-3A0EE5005DC6Q38749038-86C8764E-654D-4A12-B71F-C4443A25FDDBQ38859740-59C45DB5-F8FB-4D50-ACDE-6AB2E25747BEQ38951772-2C838688-8456-495C-9327-F51A960C8722Q41769227-CD0D994A-658F-45CE-AB17-6FC49EE08EF2Q47117702-AE1A7607-317B-4101-BFD3-70BD64978778Q47167566-69CD319A-7627-48FB-930F-7D45C6458924Q47911980-06A27CD4-0DC9-4246-9734-C52AB18E72A1Q48124426-0467B531-B517-4868-B543-736B71F27548Q49510133-D5426CD1-5436-41EA-9738-361F69C3CB5CQ49898050-6AAC1CFE-5EC4-4ED5-91F2-C92B2BB24ABDQ50870760-E1A471AD-72F3-4B56-A713-BDFF40CED93AQ52629304-96657BB1-292B-4066-AD97-9A27481E9A7FQ53467366-9A7E7843-2D8E-4A78-B461-D95FD7E72E42Q54998096-CEA0D0A3-A3EA-4031-ABEF-04331FE0C97BQ55080792-20C1A85B-C629-4451-83EC-6F248A1B8E75Q55652343-318A7122-24AE-45E3-9D42-D96CEC9D1ECBQ57063941-D030B6E1-1A0E-4A7B-85E4-C0DE61F5DD59Q57341404-E7CF49D6-A14F-4B30-B2C3-FFE8361EFB33Q58804578-BBAF5F9D-5A8A-47DF-A0F5-C198228A678C
P2860
Treatment options in patients with metastatic gastric cancer: current status and future perspectives
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment options in patients ...... status and future perspectives
@ast
Treatment options in patients ...... status and future perspectives
@en
Treatment options in patients ...... status and future perspectives
@nl
type
label
Treatment options in patients ...... status and future perspectives
@ast
Treatment options in patients ...... status and future perspectives
@en
Treatment options in patients ...... status and future perspectives
@nl
prefLabel
Treatment options in patients ...... status and future perspectives
@ast
Treatment options in patients ...... status and future perspectives
@en
Treatment options in patients ...... status and future perspectives
@nl
P2860
P356
P1476
Treatment options in patients ...... status and future perspectives
@en
P2093
Ahmet Bilici
P2860
P304
P356
10.3748/WJG.V20.I14.3905
P407
P577
2014-04-01T00:00:00Z